Bain Capital Life Sciences Investors, LLC Century Therapeutics, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $312 Million
- Q3 2025
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 3,538,609 shares of IPSC stock, worth $1.66 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
3,538,609
Previous 5,410,361
34.6%
Holding current value
$1.66 Million
Previous $3.03 Million
41.6%
% of portfolio
0.57%
Previous 0.91%
Shares
2 transactions
Others Institutions Holding IPSC
# of Institutions
56Shares Held
22.5MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.9MShares$1.36 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.59MShares$1.22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.1MShares$988,8180.0% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA1.7MShares$800,9890.23% of portfolio
-
Casdin Capital, LLC New York, NY1.23MShares$577,2490.08% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $27.7M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...